383.65
price up icon0.31%   0.1299
 
loading
Stryker Corp stock is traded at $383.65, with a volume of 69,379. It is up +0.31% in the last 24 hours and up +5.05% over the past month. Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$383.78
Open:
$381.96
24h Volume:
69,379
Relative Volume:
0.04
Market Cap:
$146.66B
Revenue:
$23.22B
Net Income/Loss:
$2.86B
P/E Ratio:
51.84
EPS:
7.4
Net Cash Flow:
$3.58B
1W Performance:
+1.38%
1M Performance:
+5.05%
6M Performance:
-0.81%
1Y Performance:
+13.46%
1-Day Range:
Value
$381.44
$385.35
1-Week Range:
Value
$371.26
$385.40
52-Week Range:
Value
$314.93
$406.19

Stryker Corp Stock (SYK) Company Profile

Name
Name
Stryker Corp
Name
Phone
(269) 385-2600
Name
Address
1941 STRYKER WAY, PORTAGE, MI
Name
Employee
53,000
Name
Twitter
Name
Next Earnings Date
2025-01-28
Name
Latest SEC Filings
Name
SYK's Discussions on Twitter

Compare SYK with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
SYK
Stryker Corp
383.76 148.87B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
ABT
Abbott Laboratories
133.31 235.23B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
105.59 157.62B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
MDT
Medtronic Plc
81.97 110.72B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.70 45.66B 5.54B 4.18B 623.10M 7.00

Stryker Corp Stock (SYK) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-26-25 Resumed Citigroup Buy
Dec-02-24 Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-10-24 Initiated Wolfe Research Outperform
May-30-24 Initiated Goldman Neutral
May-22-24 Upgrade Needham Hold → Buy
Jan-31-24 Upgrade Canaccord Genuity Hold → Buy
Oct-20-23 Initiated ROTH MKM Buy
Sep-05-23 Upgrade BofA Securities Neutral → Buy
Mar-29-23 Initiated UBS Neutral
Jan-25-23 Initiated KeyBanc Capital Markets Sector Weight
Jan-09-23 Upgrade RBC Capital Mkts Sector Perform → Outperform
Nov-01-22 Downgrade Canaccord Genuity Buy → Hold
Oct-18-22 Initiated Barclays Overweight
Oct-12-22 Initiated Jefferies Buy
Jul-28-22 Upgrade Edward Jones Hold → Buy
Jul-21-22 Downgrade Deutsche Bank Buy → Hold
Jul-11-22 Downgrade BofA Securities Buy → Neutral
Apr-13-22 Initiated Truist Hold
Mar-16-22 Upgrade Bernstein Mkt Perform → Outperform
Mar-15-22 Resumed Evercore ISI Outperform
Mar-02-22 Resumed BofA Securities Buy
Jan-07-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-04-22 Upgrade Piper Sandler Neutral → Overweight
Dec-10-21 Initiated RBC Capital Mkts Sector Perform
Dec-07-21 Initiated Loop Capital Buy
Sep-14-21 Resumed Raymond James Mkt Perform
Jul-28-21 Upgrade Northland Capital Market Perform → Outperform
Jun-01-21 Upgrade Evercore ISI In-line → Outperform
May-25-21 Initiated Barclays Underweight
Oct-06-20 Initiated Northland Capital Market Perform
Sep-11-20 Initiated Wolfe Research Peer Perform
Apr-13-20 Downgrade Barclays Equal Weight → Underweight
Apr-01-20 Downgrade Goldman Buy → Sell
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Buy
Jan-08-20 Initiated SunTrust Hold
Jan-07-20 Downgrade Piper Jaffray Overweight → Neutral
Jan-07-20 Downgrade Piper Sandler Overweight → Neutral
Dec-30-19 Reiterated BTIG Research Buy
Nov-05-19 Downgrade Barclays Overweight → Equal Weight
Oct-30-19 Reiterated BofA/Merrill Buy
Jul-02-19 Downgrade Evercore ISI Outperform → In-line
Jan-30-19 Reiterated Canaccord Genuity Buy
Jan-03-19 Initiated Deutsche Bank Buy
Jan-02-19 Upgrade Evercore ISI In-line → Outperform
Oct-16-18 Initiated Barclays Overweight
Aug-16-18 Initiated BTIG Research Buy
Jun-27-18 Initiated Bernstein Mkt Perform
Apr-27-18 Reiterated Stifel Buy
View All

Stryker Corp Stock (SYK) Latest News

pulisher
04:59 AM

Stryker tops list of West Michigan’s largest publicly traded companies - Crain's Grand Rapids Business

04:59 AM
pulisher
May 27, 2025

Jim Cramer on Stryker Corporation (SYK): “I Don’t Like It Enough” - Insider Monkey

May 27, 2025
pulisher
May 25, 2025

Stryker’s SWOT analysis: stock poised for growth amid strategic moves - Investing.com

May 25, 2025
pulisher
May 24, 2025

Stryker corp VP sells shares worth $211,369 - Investing.com Australia

May 24, 2025
pulisher
May 24, 2025

Stryker corp’s chief accounting officer sells $211,369 in shares By Investing.com - Investing.com South Africa

May 24, 2025
pulisher
May 23, 2025

Stryker corp VP sells shares worth $211,369 By Investing.com - Investing.com Nigeria

May 23, 2025
pulisher
May 23, 2025

Stryker corp’s chief accounting officer sells $211,369 in shares - Investing.com Australia

May 23, 2025
pulisher
May 23, 2025

Stryker Hits Treace With Patent Suit Over Surgical Foot-Implants - Bloomberg Law News

May 23, 2025
pulisher
May 22, 2025

Stryker Corporation: Is Its Tuck-in Acquisition Strategy to Ensure Market Leadership In The Med-Tech Landscape? - Smartkarma

May 22, 2025
pulisher
May 22, 2025

Citigroup Raises Price Target for Stryker (SYK) to $455 | SYK Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Stryker wins FDA clearance for minimally invasive back pain treatment - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

Stryker (SYK) Price Target Raised by Citi to $455 | SYK Stock Ne - GuruFocus

May 22, 2025
pulisher
May 20, 2025

Stryker (NYSE:SYK) Expands Pain Therapy With FDA Clearance For OptaBlate BVN System - Yahoo Finance

May 20, 2025
pulisher
May 20, 2025

USITC to investigate Fiagon after Stryker medical device infringement claims - MLex

May 20, 2025
pulisher
May 20, 2025

SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System - Yahoo Finance

May 20, 2025
pulisher
May 19, 2025

Stryker Receives FDA Clearance For OptaBlate System Aimed At Low Back Pain Relief: Retail’s Yet To React - Investing.com India

May 19, 2025
pulisher
May 19, 2025

Stryker (SYK) Gains FDA Clearance for OptaBlate System - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Stryker (SYK) Secures FDA Clearance for OptaBlate Nerve Ablation System | SYK Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Stryker’s new system aims at chronic back pain relief - Investing.com

May 19, 2025
pulisher
May 19, 2025

Breakthrough: FDA Approves Stryker's Revolutionary Nerve Ablation System for Chronic Back Pain Relief - Stock Titan

May 19, 2025
pulisher
May 19, 2025

Stryker Stock: Analyst Estimates & Ratings - Barchart.com

May 19, 2025
pulisher
May 18, 2025

Stryker Inks Deal to Buy One of Its Suppliers Stryker Corp. will pay $150 million for Gaymar Indu - Medical Product Outsourcing

May 18, 2025
pulisher
May 18, 2025

Boston Sci Closes Division Sale to Stryker Corp. On Jan. 3, Boston Scientific Corp. completed the - Medical Product Outsourcing

May 18, 2025
pulisher
May 18, 2025

Stryker Moves to Settle DOJ Probe - Medical Product Outsourcing

May 18, 2025
pulisher
May 18, 2025

Stryker’s Bone Growth Division Sold to Olympus Corp. Stryker Corp. has inked a deal to sell - Medical Product Outsourcing

May 18, 2025
pulisher
May 18, 2025

Insulet Adds Stryker Executive to Board - Medical Product Outsourcing

May 18, 2025
pulisher
May 18, 2025

Former Stryker CEO Receives Lifetime Achievement Award from AdvaMed - Medical Product Outsourcing

May 18, 2025
pulisher
May 18, 2025

Stryker Settles for $80 Million in Unapproved Device Sales Case - Medical Product Outsourcing

May 18, 2025
pulisher
May 18, 2025

Stryker Snaps Up Concentric for $135M - Medical Product Outsourcing

May 18, 2025
pulisher
May 18, 2025

First-Quarter Sales Strong at Stryker Corp. - Medical Product Outsourcing

May 18, 2025
pulisher
May 18, 2025

Stryker: We’re Not Buying Smith & Nephew … Yet, But We’re Interested - Medical Product Outsourcing

May 18, 2025
pulisher
May 16, 2025

SYK Q1 Earnings Call: Stryker Delivers Revenue Beat, Cites International Growth and Tariff Headwinds - Yahoo Finance

May 16, 2025
pulisher
May 15, 2025

Top Executive Sells Stryker Shares in Major Transaction - TipRanks

May 15, 2025
pulisher
May 13, 2025

Stryker Corporation (SYK) Shareholders Approve Key Incentive Pla - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Stryker Corp Shareholders Approve Incentive Plans By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Stryker at Bank of America 2025 Healthcare Conference: Strategic Growth and Innovation - Investing.com

May 13, 2025
pulisher
May 13, 2025

Stryker Corp Shareholders Approve Incentive Plans - Investing.com

May 13, 2025
pulisher
May 13, 2025

There May Be Reason For Hope In Stryker's (NYSE:SYK) Disappointing Earnings - Yahoo Finance

May 13, 2025
pulisher
May 09, 2025

Stryker: Mako Spine And Shoulder Launching Is On Track (Downgrade To Hold) (NYSE:SYK) - Seeking Alpha

May 09, 2025
pulisher
May 09, 2025

Why Stryker Corporation (SYK) Is Among the Best Medical Device Stocks to Buy Now - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Stryker Director Makes a Multi-Million Dollar Stock Move! - TipRanks

May 09, 2025
pulisher
May 08, 2025

Stryker declares an $0.84 per share quarterly dividend - Ortho Spine News

May 08, 2025
pulisher
May 08, 2025

Stryker (SYK) Announces Steady Dividend with Promising Growth Forecast - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Stryker raises dividend to $0.84 per share for Q2 - Investing.com

May 08, 2025
pulisher
May 07, 2025

Stryker Declares An $0.84 Per Share Quarterly Dividend - Barchart.com

May 07, 2025
pulisher
May 07, 2025

Here's How Much $100 Invested In Stryker 10 Years Ago Would Be Worth Today - Benzinga

May 07, 2025
pulisher
May 06, 2025

Analysts Offer Insights on Healthcare Companies: Cerus (CERS), Stryker (SYK) and Praxis Precision Medicines (PRAX) - The Globe and Mail

May 06, 2025
pulisher
May 06, 2025

Stryker (SYK) Receives Price Target Boost Following Strong Quart - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Stryker, Lockheed Martin, Rockwell Automation And More On CNBC's 'Final Trades' - Benzinga

May 06, 2025
pulisher
May 06, 2025

Reflecting On Medical Devices & SuppliesDiversified Stocks’ Q1 Earnings: Stryker (NYSE:SYK) - Yahoo Finance

May 06, 2025
pulisher
May 05, 2025

Stryker (SYK) Price Target Raised by Truist Securities | SYK Sto - GuruFocus

May 05, 2025

Stryker Corp Stock (SYK) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices BSX
$106.17
price up icon 1.60%
medical_devices MDT
$81.18
price up icon 0.86%
medical_devices ABT
$133.12
price up icon 1.37%
medical_devices EW
$76.22
price up icon 1.64%
$85.33
price up icon 0.97%
Cap:     |  Volume (24h):